Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Applied and Environmental Microbiology|August 4, 2025
CRISPR-Cas9 enables efficient genome engineering of the strictly lytic, broad-host-range staphylococcal bacteriophage KJonas Fernbach, Jasmin Baggenstos, Ellen-Aleksandra Svorjova, et al.
Frontiers in Medicine|May 12, 2025
Bacteriophage therapy created the necessary conditions for successful antibiotic suppression in a periprosthetic hip joint infection: a Case ReportPeter Wahl, Michel Schläppi, Archana Loganathan, et al.
Artificial Organs|October 15, 2019
Efficient decellularization of equine tendon with preserved biomechanical properties and cytocompatibility for human tendon surgery indicationsPierre-Arnaud Aeberhard, Anthony Grognuz, Cédric Peneveyre, et al.
Journal of Bone and Joint Infection|April 13, 2022
Short and oral antimicrobial therapy for diabetic foot infection: a narrative review of current knowledgeSteven M Maurer, Zehra S Hepp, Shawna McCallin, et al.
Virology|June 13, 2013
Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjectsShawna McCallin, Shafiqul Alam Sarker, Caroline Barretto, et al.
Virology|October 30, 2012
Oral T4-like phage cocktail application to healthy adult volunteers from BangladeshShafiqul Alam Sarker, Shawna McCallin, Caroline Barretto, et al.
BMC Infectious Diseases|August 2, 2023
Indwelling catheter vs intermittent catheterization: is there a difference in UTI susceptibility?Vera Neumeier, Fabian P Stangl, Joëlle Borer, et al.
The Lancet. Infectious Diseases|September 19, 2020
Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trialLorenz Leitner, Aleksandre Ujmajuridze, Nina Chanishvili, et al.
Nature Communications|June 27, 2023
Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosaThilo Köhler, Alexandre Luscher, Léna Falconnet, et al.
JAMA|June 3, 2020
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical TrialElodie von Dach, Werner C Albrich, Anne-Sophie Brunel, et al.
Pageof 3